NRC. 1994. Science and judgment in risk assessment. Washington, DC: National Academy Press.

NRC. 1996. Understanding risk: Informing decisions in a democratic society. Washington, DC: National Academy Press.

NRC. 2009. Science and decisions: Advancing risk assessment. Washington, DC: The National Academies Press.

NRC. 2011. A risk-characterization framework for decision-making at the Food and Drug Administration. Washington, DC: The National Academies Press.

O’Reilly, J. T. 2008. Losing deference in the FDA’s second century: Judicial review, politics, and a diminished legacy of expertise. Cornell Law Rev 93(5):939-980.

Patel, M. M., V. R. López-Collada, M. M. Bulhões, L. H. De Oliveira, A. B. Márquez, B. Flannery, M. Esparza-Aguilar, E. I. Montenegro Renoiner, M. E. Luna-Cruz, H. K. Sato, L. d. C. Hernández-Hernández, G. Toledo-Cortina, M. Cerón-Rodríguez, N. Osnaya-Romero, M. Martínez-Alcazar, R. G. Aguinaga-Villasenor, A. Plascencia-Hernández, F. Fojaco-González, G. Hernández-Peredo Rezk, S. F. Gutierrez-Ramírez, R. Dorame-Castillo, R. Tinajero-Pizano, B. Mercado-Villegas, M. R. Barbosa, E. M. C. Maluf, L. B. Ferreira, F. M. de Carvalho, A. R. dos Santos, E. D. Cesar, M. E. P. de Oliveira, C. L. Osterno Silva, M. de los Angeles Cortes, C. Ruiz Matus, J. Tate, P. Gargiullo, and U. D. Parashar. 2011. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. New England Journal of Medicine 364(24):2283-2292.

PhRMA (Pharmaceutical Research and Manufacturers of America). 2012. PhRMA transitions management of benefit-risk action team framework to CIRS. http://www.phrma.org/media/releases/phrma-transitions-management-benefit-risk-action-team-framework-cirs (accessed February 18, 2012).

Pidgeon, N., and B. Fischhoff. 2011. The role of social and decision sciences in communicating uncertain climate risks. Nature Climate Change 1:35-41.

Prentice, R. L. 1989. Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8(4):431-440.

Presidential/Congressional Commission on Risk Assessment and Risk Management. 1997. Risk assessment and risk management in regulatory decision-making. Final report. Volume 2. http://www.riskworld.com/Nreports/1997/risk-rpt/volume2/pdf/v2epa.PDF (accessed September 15, 2008).

Psaty, B. M., N. S. Weiss, C. D. Furberg, T. D. Koepsell, D. S. Sisčovick, F. R. Rosendaal, N. L. Smith, S. R. Heckbert, R. C. Kaplan, D. Lin, T. R. Fleming, and E. H. Wagner. 1999. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA 282(8):786-790.

Raiffa, H. 1968. Decision analysis. In Tools for making acute risk decisions: With chemical process safety applications. Hoboken, NJ: John Wiley & Sons, Inc.

Ray, W. A., and C. M. Stein. 2006. Reform of drug regulation—beyond an independent drug-safety board. New England Journal of Medicine 354(2):194-201.

Richardson, W. S., M. C. Wilson, J. Nishikawa, and R. S. Hayward. 1995. The well-built clinical question: A key to evidence-based decisions. ACP Journal Club 123(3):A12-13.

Rossebo, A. B., T. R. Pedersen, K. Boman, P. Brudi, J. B. Chambers, K. Egstrup, E. Gerdts, C. Gohlke-Bärwolf, I. Holme, Y. A. Kesäniemi, W. Malbecq, C. A. Nienaber, S. Ray, T. Skjærpe, K. Wachtell, and R. Willenheimer. 2008. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine 359(13):1343-1356.

Rothman, S. M., V. H. Raveis, A. Friedman, and D. J. Rothman. 2011. Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices. American Journal of Public Health 101(4):602-609.

Schneeweiss, S., J. D. Seeger, J. Landon, and A. M. Walker. 2008. Aprotinin during coronary-artery bypass grafting and risk of death. New England Journal of Medicine 358(8):771-783.

Sedrakyan, A., T. Treasure, and J. A. Elefteriades. 2004. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. The Journal of Thoracic and Cardiovascular Surgery 128(3):442-448.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement